Literature DB >> 8777154

Screening by the prostate-specific antigen test: what do the patients know?

P N Diefenbach1, P A Ganz, A J Pawlow, D Guthrie.   

Abstract

BACKGROUND: Prostate cancer is the most common malignancy in men, and prostate cancer screening is recommended for all men over the age of 50. The use of the prostate-specific antigen (PSA) test for cancer screening is controversial.
METHODS: At two different Veterans Administration facilities, outpatients completed a 15-item questionnaire about their knowledge of the PSA test two weeks after receiving a screening test.
RESULTS: Demographic characteristics of the patients are described and examined in relation to the results of the PSA-test-knowledge questions. Over 50% of men had not heard of the PSA test and were unaware of receiving the test. Higher education level was the only predictor of PSA-test knowledge.
CONCLUSIONS: Either patients forget information about the PSA test or providers do not tell patients they are being screened for cancer. Further research and interventions are needed to improve patient knowledge and understanding about this prostate cancer screening test.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777154     DOI: 10.1080/08858199609528390

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  10 in total

1.  Knowledge, attitudes, and screening practices among older men regarding prostate cancer.

Authors:  C B Steele; D S Miller; C Maylahn; R J Uhler; C T Baker
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

2.  A population-based survey of prostate cancer testing in New Mexico.

Authors:  R M Hoffman; F D Gilliland
Journal:  J Community Health       Date:  1999-12

3.  PSA--"prostate-specific antigen" or "patient stress & anxiety": a questionnaire study.

Authors:  Junaid Masood; Azhar Khan; Taufiq Sheikh; Noor Buchholz; Ron Miller; Andrew J Ball
Journal:  Int Urol Nephrol       Date:  2007-04-06       Impact factor: 2.370

4.  Informed decision making about prostate cancer testing in predominantly immigrant black men: a randomized controlled trial.

Authors:  Stephen J Lepore; Randi L Wolf; Charles E Basch; Melissa Godfrey; Emma McGinty; Celia Shmukler; Ralph Ullman; Nigel Thomas; Sally Weinrich
Journal:  Ann Behav Med       Date:  2012-12

5.  National evidence on the use of shared decision making in prostate-specific antigen screening.

Authors:  Paul K J Han; Sarah Kobrin; Nancy Breen; Djenaba A Joseph; Jun Li; Dominick L Frosch; Carrie N Klabunde
Journal:  Ann Fam Med       Date:  2013 Jul-Aug       Impact factor: 5.166

6.  PSA testing: are patients aware of what lies ahead?

Authors:  Marc Lamplugh; Paul Gilmore; Timothy Quinlan; Philip Cornford
Journal:  Ann R Coll Surg Engl       Date:  2006-05       Impact factor: 1.891

7.  Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?

Authors:  Evelyn C Y Chan; Sally W Vernon; Frederick T O'Donnell; Chul Ahn; Anthony Greisinger; Donnie W Aga
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

8.  Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing.

Authors:  Evelyn C Y Chan; Sally W Vernon; Michelle C Haynes; Frederick T O'Donnell; Chul Ahn
Journal:  J Gen Intern Med       Date:  2003-05       Impact factor: 5.128

9.  Cultural sensitivity and informed decision making about prostate cancer screening.

Authors:  Evelyn C Y Chan; Michelle C Haynes; Frederick T O'Donnell; Carolyn Bachino; Sally W Vernon
Journal:  J Community Health       Date:  2003-12

10.  Communication message strategies for increasing knowledge about prostate cancer screening.

Authors:  Lauren A McCormack; Carla M Bann; Pamela Williams-Piehota; David Driscoll; Cindy Soloe; Jon Poehlman; Tzy-Mey Kuo; Kathleen N Lohr; Stacey L Sheridan; Carol E Golin; Russell Harris; Samuel Cykert
Journal:  J Cancer Educ       Date:  2009       Impact factor: 2.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.